The Ensign Group, Inc. (ENSG)
USD 128.17
(-0.01%)
USD 128.17
(-0.01%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.72 Billion USD | 23.27% |
| 2022 | 3.02 Billion USD | 15.15% |
| 2021 | 2.62 Billion USD | 9.36% |
| 2020 | 2.4 Billion USD | 17.98% |
| 2019 | 2.03 Billion USD | -1.78% |
| 2018 | 2.07 Billion USD | 12.12% |
| 2017 | 1.84 Billion USD | 11.75% |
| 2016 | 1.65 Billion USD | 23.33% |
| 2015 | 1.34 Billion USD | 30.6% |
| 2014 | 1.02 Billion USD | 13.58% |
| 2013 | 904.55 Million USD | 9.68% |
| 2012 | 824.71 Million USD | 8.76% |
| 2011 | 758.27 Million USD | 16.74% |
| 2010 | 649.53 Million USD | 19.84% |
| 2009 | 542 Million USD | 15.47% |
| 2008 | 469.37 Million USD | 14.11% |
| 2007 | 411.31 Million USD | 14.71% |
| 2006 | 358.57 Million USD | 19.19% |
| 2005 | 300.85 Million USD | 23.03% |
| 2004 | 244.53 Million USD | 54.76% |
| 2003 | 158 Million USD | 54.75% |
| 2002 | 102.1 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.03 Billion USD | 5.43% |
| 2024 Q1 | 982.9 Million USD | 0.26% |
| 2024 Q3 | 1.08 Billion USD | 4.39% |
| 2023 Q1 | 886.84 Million USD | 9.55% |
| 2023 Q3 | 940.79 Million USD | 2.11% |
| 2023 Q4 | 980.37 Million USD | 4.21% |
| 2023 Q2 | 921.34 Million USD | 3.89% |
| 2023 FY | 3.72 Billion USD | 23.27% |
| 2022 Q1 | 713.44 Million USD | 2.93% |
| 2022 Q4 | 809.53 Million USD | 5.13% |
| 2022 FY | 3.02 Billion USD | 15.15% |
| 2022 Q3 | 770 Million USD | 5.12% |
| 2022 Q2 | 732.48 Million USD | 2.67% |
| 2021 Q4 | 693.14 Million USD | 3.68% |
| 2021 FY | 2.62 Billion USD | 9.36% |
| 2021 Q1 | 627.25 Million USD | -0.28% |
| 2021 Q2 | 638.53 Million USD | 1.8% |
| 2021 Q3 | 668.53 Million USD | 4.7% |
| 2020 FY | 2.4 Billion USD | 17.98% |
| 2020 Q1 | 589.61 Million USD | 5.25% |
| 2020 Q4 | 629.02 Million USD | 4.97% |
| 2020 Q3 | 599.25 Million USD | 2.49% |
| 2020 Q2 | 584.69 Million USD | -0.83% |
| 2019 Q3 | 600.5 Million USD | 4.32% |
| 2019 Q4 | 560.19 Million USD | -6.71% |
| 2019 FY | 2.03 Billion USD | -1.78% |
| 2019 Q1 | 549.21 Million USD | 0.8% |
| 2019 Q2 | 575.65 Million USD | 4.81% |
| 2018 FY | 2.07 Billion USD | 12.12% |
| 2018 Q3 | 514.36 Million USD | 3.62% |
| 2018 Q2 | 496.38 Million USD | 0.86% |
| 2018 Q4 | 544.84 Million USD | 5.93% |
| 2018 Q1 | 492.13 Million USD | 0.91% |
| 2017 Q4 | 487.7 Million USD | 3.42% |
| 2017 FY | 1.84 Billion USD | 11.75% |
| 2017 Q3 | 471.59 Million USD | 5.2% |
| 2017 Q1 | 441.73 Million USD | 2.01% |
| 2017 Q2 | 448.27 Million USD | 1.48% |
| 2016 Q2 | 410.51 Million USD | 7.12% |
| 2016 Q1 | 383.23 Million USD | 2.7% |
| 2016 Q3 | 428.06 Million USD | 4.27% |
| 2016 FY | 1.65 Billion USD | 23.33% |
| 2016 Q4 | 433.04 Million USD | 1.16% |
| 2015 FY | 1.34 Billion USD | 30.6% |
| 2015 Q3 | 351.08 Million USD | 12.87% |
| 2015 Q2 | 311.05 Million USD | 1.48% |
| 2015 Q1 | 306.52 Million USD | 10.71% |
| 2015 Q4 | 373.15 Million USD | 6.29% |
| 2014 Q4 | 276.86 Million USD | 6.14% |
| 2014 Q1 | 239.65 Million USD | 1.12% |
| 2014 Q2 | 250.04 Million USD | 4.34% |
| 2014 FY | 1.02 Billion USD | 13.58% |
| 2014 Q3 | 260.84 Million USD | 4.32% |
| 2013 Q3 | 229.26 Million USD | 4.17% |
| 2013 Q2 | 220.08 Million USD | 0.86% |
| 2013 FY | 904.55 Million USD | 9.68% |
| 2013 Q4 | 237 Million USD | 3.38% |
| 2013 Q1 | 218.2 Million USD | 3.36% |
| 2012 FY | 824.71 Million USD | 8.76% |
| 2012 Q1 | 202.16 Million USD | 4.93% |
| 2012 Q2 | 204.3 Million USD | 1.06% |
| 2012 Q3 | 207.15 Million USD | 1.39% |
| 2012 Q4 | 211.1 Million USD | 1.91% |
| 2011 Q1 | 182.94 Million USD | 5.9% |
| 2011 Q2 | 186.32 Million USD | 1.85% |
| 2011 Q4 | 192.66 Million USD | -1.88% |
| 2011 FY | 758.27 Million USD | 16.74% |
| 2011 Q3 | 196.34 Million USD | 5.38% |
| 2010 Q1 | 154.17 Million USD | 5.16% |
| 2010 Q4 | 172.75 Million USD | 4.92% |
| 2010 FY | 649.53 Million USD | 19.84% |
| 2010 Q3 | 164.65 Million USD | 4.25% |
| 2010 Q2 | 157.94 Million USD | 2.45% |
| 2009 Q2 | 132.17 Million USD | 1.45% |
| 2009 Q1 | 130.28 Million USD | 5.11% |
| 2009 Q3 | 132.92 Million USD | 0.56% |
| 2009 Q4 | 146.61 Million USD | 10.3% |
| 2009 FY | 542 Million USD | 15.47% |
| 2008 Q1 | 113.77 Million USD | 4.4% |
| 2008 Q4 | 123.94 Million USD | 6.55% |
| 2008 Q3 | 116.32 Million USD | 0.88% |
| 2008 Q2 | 115.31 Million USD | 1.35% |
| 2008 FY | 469.37 Million USD | 14.11% |
| 2007 Q4 | 108.97 Million USD | 4.69% |
| 2007 Q3 | 104.09 Million USD | 3.81% |
| 2007 Q1 | 97.97 Million USD | 9.3% |
| 2007 FY | 411.31 Million USD | 14.71% |
| 2007 Q2 | 100.26 Million USD | 2.34% |
| 2006 Q1 | 89.64 Million USD | 19.19% |
| 2006 Q2 | 89.64 Million USD | 0.0% |
| 2006 Q3 | 89.64 Million USD | 0.0% |
| 2006 FY | 358.57 Million USD | 19.19% |
| 2006 Q4 | 89.64 Million USD | -0.0% |
| 2005 FY | 300.85 Million USD | 23.03% |
| 2005 Q3 | 75.21 Million USD | 0.0% |
| 2005 Q4 | 75.21 Million USD | -0.0% |
| 2005 Q2 | 75.21 Million USD | 0.0% |
| 2005 Q1 | 75.21 Million USD | 0.0% |
| 2004 FY | 244.53 Million USD | 54.76% |
| 2003 FY | 158 Million USD | 54.75% |
| 2002 FY | 102.1 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | -27.337% |
| Addus HomeCare Corporation | 1.05 Billion USD | -252.274% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -1803.538% |
| Amedisys, Inc. | 2.23 Billion USD | -66.758% |
| American Oncology Network, Inc. | 1.27 Billion USD | -191.541% |
| Astrana Health, Inc. | 1.38 Billion USD | -168.945% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | -96.778% |
| IMAC Holdings, Inc. | 5.19 Million USD | -71659.765% |
| biote Corp. | 185.36 Million USD | -1911.952% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -11798.262% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | -84.646% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -497.377% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | -123.129% |
| InnovAge Holding Corp. | 763.85 Million USD | -388.228% |
| Assure Holdings Corp. | 255 Thousand USD | -1462392.157% |
| The Joint Corp. | 117.69 Million USD | -3068.624% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -253.271% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -35902.789% |
| ModivCare Inc. | 2.75 Billion USD | -35.555% |
| NewGenIvf Group Limited | 5.13 Million USD | -72509.889% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -29563.931% |
| Option Care Health, Inc. | 4.3 Billion USD | 13.318% |
| P3 Health Partners Inc. | 1.26 Billion USD | -194.491% |
| P3 Health Partners Inc. | 1.26 Billion USD | -194.491% |
| The Pennant Group, Inc. | 544.89 Million USD | -584.422% |
| Surgery Partners, Inc. | 2.74 Billion USD | -35.944% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -67520.265% |
| Talkspace, Inc. | 150.04 Million USD | -2385.491% |
| Talkspace, Inc. | 150.04 Million USD | -2385.491% |
| The Oncology Institute, Inc. | 324.23 Million USD | -1050.187% |
| The Oncology Institute, Inc. | 324.23 Million USD | -1050.187% |